AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 155 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $62,000 | -70.3% | 86,593 | -6.6% | 0.00% | -100.0% |
Q4 2021 | $209,000 | -24.0% | 92,688 | -2.9% | 0.00% | 0.0% |
Q3 2021 | $275,000 | -18.9% | 95,461 | +6.6% | 0.00% | 0.0% |
Q2 2021 | $339,000 | +19.8% | 89,538 | +7.3% | 0.00% | 0.0% |
Q1 2021 | $283,000 | +21.5% | 83,472 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $233,000 | +8.4% | 83,252 | -2.8% | 0.00% | 0.0% |
Q3 2020 | $215,000 | -80.1% | 85,640 | +7.6% | 0.00% | -80.0% |
Q2 2020 | $1,081,000 | +104.0% | 79,611 | +13.9% | 0.01% | +66.7% |
Q1 2020 | $530,000 | +13.5% | 69,887 | -5.5% | 0.00% | +50.0% |
Q4 2019 | $467,000 | +59.9% | 73,926 | -0.8% | 0.00% | +100.0% |
Q3 2019 | $292,000 | -19.6% | 74,548 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $363,000 | -19.0% | 75,068 | +37.2% | 0.00% | -50.0% |
Q1 2019 | $448,000 | +43.6% | 54,714 | -3.1% | 0.00% | +100.0% |
Q4 2018 | $312,000 | +5.8% | 56,486 | +68.9% | 0.00% | 0.0% |
Q3 2018 | $295,000 | -10.1% | 33,448 | +1.8% | 0.00% | 0.0% |
Q2 2018 | $328,000 | +20.1% | 32,846 | +14.8% | 0.00% | 0.0% |
Q1 2018 | $273,000 | -39.1% | 28,613 | -5.1% | 0.00% | 0.0% |
Q4 2017 | $448,000 | -23.4% | 30,151 | +1.5% | 0.00% | -50.0% |
Q3 2017 | $585,000 | +77.8% | 29,720 | +29.9% | 0.00% | +100.0% |
Q2 2017 | $329,000 | +61.3% | 22,884 | +3.4% | 0.00% | 0.0% |
Q1 2017 | $204,000 | -5.1% | 22,121 | +7.1% | 0.00% | 0.0% |
Q4 2016 | $215,000 | -99.9% | 20,661 | -0.3% | 0.00% | 0.0% |
Q3 2016 | $187,471,000 | +21.2% | 20,715 | +0.1% | 0.00% | 0.0% |
Q2 2016 | $154,716,000 | +19.9% | 20,684 | +44.9% | 0.00% | 0.0% |
Q1 2016 | $129,000,000 | -29.9% | 14,279 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $184,000,000 | +133233.3% | 14,279 | -0.2% | 0.00% | 0.0% |
Q3 2015 | $138,000 | -99.9% | 14,304 | +0.1% | 0.00% | 0.0% |
Q2 2015 | $147,013,000 | +168.6% | 14,287 | +190.0% | 0.00% | – |
Q1 2015 | $54,728,000 | -4.6% | 4,926 | 0.0% | 0.00% | – |
Q4 2014 | $57,339,000 | -49.4% | 4,926 | -3.8% | 0.00% | – |
Q3 2014 | $113,328,000 | -20.4% | 5,121 | -0.1% | 0.00% | -100.0% |
Q2 2014 | $142,396,000 | – | 5,124 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |